Syrinx Pharmaceuticals

Syrinx Pharmaceuticals supplies a range of nutraceuticals medicines for skincare, bone and joint health, lifestyle, and more. They pioneered their WaferiX which provides rapid and superior absorption characteristics.

Synrinx Pharmaceuticals is a fully integrated business providing end-to-end product development and manufacturing services for pharmaceutical and nutraceutical products.

Some of the services they offer are formulation development, analytical services, contract manufacturing, regulatory and clinical trial consultation, as well as storage and handling.

Some of the quality certifications they hold are:

Certificate of GMP Compliance of a Manufacturer (Therapeutic Goods Administration)
License to Manufacture and Sell or Supply by Wholesale Schedule 8 Poisons (Therapeutic Goods Administration)
Medicinal Cannabis Manufacture License (Department of Health Office of Drug Control)
License to Manufacture Veterinary Chemical Products (Australian Pesticides and Veterinary Medicines Authority)
Halal Certificate for iX Biopharma and Entity Products (Islamic Co-ordinating Council of Victoria)

Syrinx Pharmaceuticals manufactures Xativa, the world’s first medicinal cannabis sublingual wafer.

This product offers improved absorption, reduced variability and fixed unit dosing. They develop formulations for oral and topical dosage of human and veterinary pharmaceutical drug and health supplement products.

Specializing in high performance liquid chromatography, their laboratory has the equipment to conduct analytical assay and related substances testing of raw materials and finished products including method development, method validation, stability and release testing.

Syrinx Pharmaceuticals also has stability storage chamber facilities that are constructed to temperature and humidity conditions in accordance with relevant ICH guidelines. They also have facilities for photo-stability testing of products, cGMP pharmaceutical-grade manufacturing, packaging and labelling for domestic and international clinical and commercial programs.

Part of their expertise includes assisting clients in meeting Australian and overseas registration requirements, with early development capabilities including candidate selection, PK modeling, formulations for GLP studies and candidate screening and selection.

Syrinx Pharmaceuticals manufactures pharmaceuticals, nutraceuticals and medicinal cannabis. They can be found at 110 Merrindale Drive, Croydon VIC 3136, Australia. For more information, send them an email at info@ixsyrinx.com or give them a call at +61 3 9737 4333.